-
Press Releases
- 08/02/22Bioengineered Head Device Stops Alzheimer’s Memory Loss for 2 1⁄2 Years06/06/22Groundbreaking Alzheimer’s Treatment Study03/24/22NeuroEM Therapeutics Awarded $2.2M Grant from National Institute on Aging for Promising Device Against Alzheimer’s Disease10/28/20First-Ever Treatment Shown to Reverse Alzheimer’s Earns NeuroEM Therapeutics FDA Breakthrough Device Status09/16/19Alzheimer’s Memory Loss Reversed by New Head Device Using Electromagnetic Waves01/08/19NeuroEM Therapeutics Announces Completion of Clinical Trial Testing Its Novel Head Device Against Alzheimer’s Disease07/28/17Alzheimer’s Clinical Trial Begins with Pioneering Medical Device12/08/16National Institutes of Health Bestows Grant to NeuroEM Therapeutics and Arizona State University for Collaborative Research in Alzheimer’s Disease11/23/16NeuroEM Therapeutic’s CEO provides keynote address at Australian conference on biologic effects of electromagnetic exposure05/02/16Angel Investment Forum Provides “Series Seed” Funding to NeuroEM Therapeutics to Support Development of Medical Device against Alzheimer’s Disease